Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
(2026) In Nature Cell Biology- Abstract
Aggressive tumours are defined by microenvironmental stress adaptation and metabolic reprogramming. Within this niche, lipid droplet accumulation has emerged as a key strategy to buffer toxic lipids and suppress ferroptosis. Lipid droplet formation can occur via de novo lipogenesis or extracellular lipid-scavenging. However, how tumour cells coordinate these processes remains poorly understood. Here we identify a chondroitin sulfate (CS)-enriched glycocalyx as a hallmark of the acidic microenvironment in glioblastoma and central nervous system metastases. This CS-rich glycocalyx encapsulates tumour cells, limits lipid particle uptake and protects against lipid-induced ferroptosis. Mechanistically, we demonstrate that converging... (More)
Aggressive tumours are defined by microenvironmental stress adaptation and metabolic reprogramming. Within this niche, lipid droplet accumulation has emerged as a key strategy to buffer toxic lipids and suppress ferroptosis. Lipid droplet formation can occur via de novo lipogenesis or extracellular lipid-scavenging. However, how tumour cells coordinate these processes remains poorly understood. Here we identify a chondroitin sulfate (CS)-enriched glycocalyx as a hallmark of the acidic microenvironment in glioblastoma and central nervous system metastases. This CS-rich glycocalyx encapsulates tumour cells, limits lipid particle uptake and protects against lipid-induced ferroptosis. Mechanistically, we demonstrate that converging hypoxia-inducible factor and transforming growth factor beta signalling induces a glycan switch on syndecan-1-replacing heparan sulfate with CS-thereby impairing its lipid-scavenging function. Dual inhibition of CS biosynthesis and diacylglycerol O-acyltransferase-1, a critical enzyme in lipid droplet formation, triggers catastrophic lipid peroxidation and ferroptotic cell death. These findings define glycan remodelling as a core determinant of metabolic plasticity, positioning the dynamic glycocalyx as a master regulator of nutrient access, ferroptotic sensitivity and therapeutic vulnerability in cancer.
(Less)
- author
- organization
-
- Tumor microenvironment (research group)
- Research Group Lung Cancer (research group)
- LUCC: Lund University Cancer Centre
- RNA Therapeutics in Cancer (research group)
- Neurosurgery
- Cancerepidemiology and radiation
- Glioma immunotherapy group (research group)
- Lund OsteoArthritis Division - Molecular marker research group (research group)
- Lung Biology (research group)
- Lund Laser Centre, LLC
- LTH Profile Area: Photon Science and Technology
- eSSENCE: The e-Science Collaboration
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- publishing date
- 2026-02-11
- type
- Contribution to journal
- publication status
- epub
- subject
- in
- Nature Cell Biology
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:41673170
- ISSN
- 1465-7392
- DOI
- 10.1038/s41556-026-01879-y
- language
- English
- LU publication?
- yes
- additional info
- © 2026. The Author(s).
- id
- 3e19b355-33b7-4a07-8c46-4ac4945d2597
- date added to LUP
- 2026-02-26 13:58:46
- date last changed
- 2026-02-26 13:58:46
@article{3e19b355-33b7-4a07-8c46-4ac4945d2597,
abstract = {{<p>Aggressive tumours are defined by microenvironmental stress adaptation and metabolic reprogramming. Within this niche, lipid droplet accumulation has emerged as a key strategy to buffer toxic lipids and suppress ferroptosis. Lipid droplet formation can occur via de novo lipogenesis or extracellular lipid-scavenging. However, how tumour cells coordinate these processes remains poorly understood. Here we identify a chondroitin sulfate (CS)-enriched glycocalyx as a hallmark of the acidic microenvironment in glioblastoma and central nervous system metastases. This CS-rich glycocalyx encapsulates tumour cells, limits lipid particle uptake and protects against lipid-induced ferroptosis. Mechanistically, we demonstrate that converging hypoxia-inducible factor and transforming growth factor beta signalling induces a glycan switch on syndecan-1-replacing heparan sulfate with CS-thereby impairing its lipid-scavenging function. Dual inhibition of CS biosynthesis and diacylglycerol O-acyltransferase-1, a critical enzyme in lipid droplet formation, triggers catastrophic lipid peroxidation and ferroptotic cell death. These findings define glycan remodelling as a core determinant of metabolic plasticity, positioning the dynamic glycocalyx as a master regulator of nutrient access, ferroptotic sensitivity and therapeutic vulnerability in cancer.</p>}},
author = {{Bång-Rudenstam, Anna and Cerezo-Magaña, Myriam and Horvath, Marton and Talbot, Hugo and Gustafsson, Emma and Jonathan, Stevanus and Chakraborty, Chaitali and Nissen, Itzel and Gonçalves de Oliveira, Kelin and Boukredine, Axel and Beyer, Sarah and Perez, Julio Enriquez and Johansson, Maria C and Kjellén, Lena and Tykesson, Emil and Malmström, Anders and van Kuppevelt, Toin H and Forsberg-Nilsson, Karin and Esko, Jeffrey D and Remeseiro, Silvia and Bengzon, Johan and Governa, Valeria and Belting, Mattias}},
issn = {{1465-7392}},
language = {{eng}},
month = {{02}},
publisher = {{Nature Publishing Group}},
series = {{Nature Cell Biology}},
title = {{Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis}},
url = {{http://dx.doi.org/10.1038/s41556-026-01879-y}},
doi = {{10.1038/s41556-026-01879-y}},
year = {{2026}},
}
